What does Adicet Bio, Inc. do?
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that…
What is Adicet Bio, Inc.'s P/E and P/B ratio?
Adicet Bio, Inc. has a P/E ratio of -0.4 and a P/B ratio of 0.33.
What is Adicet Bio, Inc.'s debt-to-equity ratio?
Adicet Bio, Inc. has a debt-to-equity ratio of 0.11.
How much does Adicet Bio, Inc. owe compared with what it owns?
Adicet Bio, Inc. owes $0.19 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Adicet Bio, Inc.'s Positivity rank?
Adicet Bio, Inc. is ranked #1,759 of 6,774 companies globally and #435 of 4,000 in United States on PositoAI, with a Positivity Score of 22,340.
Does Adicet Bio, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Adicet Bio, Inc..
Where can I read the latest news about Adicet Bio, Inc.?
Recent headlines about Adicet Bio, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Adicet Bio, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Adicet Bio, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.